Advertisement
Advertisement

EVGN

EVGN logo

EVOGENE LTD.

0.63
USD
Sponsored
+0.03
+5.37%
Aug 10, 15:59 UTC -4
Closed
exchange

After-Market

0.63

0.00
-0.52%

EVOGENE LTD. Profile

About

Evogene is a leading computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. Incorporating a deep understanding of biology and leveraging Big Data and Artificial Intelligence, Evogene established its unique technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. Evogene holds a number of subsidiaries utilizing the CPB platform to develop human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production.

Info & Links

CEO

Ofer Haviv

Headquarters

13 GAD FEINSTEIN STREET,PARK REHOVOT
REHOVOT, L3 7638517, ISRAEL

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.evogene.com

Auditor

KOST FORER GABBAY & KASIERER

Share holders

--

Employees

52

EVOGENE LTD. Statistics

Valuation Measures

Market Capitalization2

7.61M

Enterprise Value

-929.30K

Enterprise Value/EBITDA(ttm)

0.09

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

2.84

Price to Book(mrq)

0.65

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

-108.00%

Operating Margin(ttm)

-1067.84%

Profit Margin(ttm)

-677.91%

Return on Equity(ttm)

-158.82%

Return on Invested Capital(ttm)

-162.57%

Return on Assets(ttm)

-80.37%

Income Statement

Revenue(ttm)

1.84M

Revenue Per Share(ttm)

--

Gross Profit(ttm)

-863.00K

EBITDA(ttm)3

-10.41M

Net Income Available to Common(ttm)

-11.77M

Diluted EPS(ttm)

-1.39

Share Statistics

Beta (5Y Monthly)

1.40

52-Week Change

-47.74%

S&P 500 52-Week Change

21.65%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

8.07M

% Held by Insiders

7.40%

% Held by Institutions

10.40%

Balance Sheet

Total Cash(mrq)

13.09M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.79%

Quick Ratio(mrq)

2.76%

Book Value Per Share(mrq)

0.77

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.30

Free Cash Flow(ytd)

-2.93M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement